Cite

HARVARD Citation

    Reck, M. et al. (n.d.). 1193PDAnalysis of tumour hyperprogression (HP) with nivolumab (Nivo) in randomized, placebo (Pbo)-controlled trials. Annals of oncology. p. . [Online]. 
  
Back to record